NFE2L2 and renal cell carcinoma: AlphaFold predictions revealed high‐confidence interactions involving various RCC drivers, including TCEB1, NRF2, subunits of the COMPASS‐related complexes, the TSC complexes in the MTOR pathway, and complexes involving TRRAP.